These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12109914)

  • 1. Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.
    Nguyen NH; Apriletti JW; Cunha Lima ST; Webb P; Baxter JD; Scanlan TS
    J Med Chem; 2002 Jul; 45(15):3310-20. PubMed ID: 12109914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines.
    Shah V; Nguyen P; Nguyen NH; Togashi M; Scanlan TS; Baxter JD; Webb P
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):69-77. PubMed ID: 18930112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
    Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
    Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor.
    Meng X; Yang YF; Cao X; Govindan MV; Shuen M; Hollenberg AN; Mymryk JS; Walfish PG
    Mol Endocrinol; 2003 Jun; 17(6):1095-105. PubMed ID: 12637585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression.
    Gloss B; Giannocco G; Swanson EA; Moriscot AS; Chiellini G; Scanlan T; Baxter JD; Dillmann WH
    Endocrinology; 2005 Nov; 146(11):4926-33. PubMed ID: 16081636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivatives.
    Chiellini G; Nguyen NH; Apriletti JW; Baxter JD; Scanlan TS
    Bioorg Med Chem; 2002 Feb; 10(2):333-46. PubMed ID: 11741782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone action is disrupted by bisphenol A as an antagonist.
    Moriyama K; Tagami T; Akamizu T; Usui T; Saijo M; Kanamoto N; Hataya Y; Shimatsu A; Kuzuya H; Nakao K
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5185-90. PubMed ID: 12414890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists.
    Nguyen NH; Apriletti JW; Baxter JD; Scanlan TS
    J Am Chem Soc; 2005 Apr; 127(13):4599-608. PubMed ID: 15796525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
    J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of thyroid hormone receptor antagonists from first principles.
    Webb P; Nguyen NH; Chiellini G; Yoshihara HA; Cunha Lima ST; Apriletti JW; Ribeiro RC; Marimuthu A; West BL; Goede P; Mellstrom K; Nilsson S; Kushner PJ; Fletterick RJ; Scanlan TS; Baxter JD
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):59-73. PubMed ID: 12650702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
    Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
    Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1.
    Nishiyama K; Matsushita A; Natsume H; Mikami T; Genma R; Sasaki S; Nakamura H
    J Endocrinol; 2000 Nov; 167(2):219-27. PubMed ID: 11054635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coactivator and corepressor complexes in nuclear receptor function.
    Xu L; Glass CK; Rosenfeld MG
    Curr Opin Genet Dev; 1999 Apr; 9(2):140-7. PubMed ID: 10322133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.